+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Needle-Free Drug Delivery Devices Market Analysis & Forecast to 2024-2034

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5923154
The global needle-free drug delivery devices market size was estimated to be USD 18.86 billion in 2023 and is expected to reach at USD 43.75 billion by 2034 with a CAGR of 7.95% during the forecast period 2024-2034. Expanding diabetic patient population, growing ease of access to Type 1 diabetes care, rising demand & technological advancements in the field of painless drug delivery & self-administration, increasing prevalence of infectious diseases such as hepatitis, dengue fever, neurological disorders, & AIDS, well-established healthcare facilities, government organizations & pharmaceutical companies are increasingly initiating efforts to fund extensive research & development costs for diabetes & chronic pain cases, surge in technological advancements in painless drug delivery, growing development of a self-administered disposable subcutaneous medication transport system, rising prevalence of chronic diseases, increasing research activities for the development of technologically advanced needle-free drug delivery devices, and surge in launch of needle-free drug delivery devices are some of the key factors boosting the market growth.

Surge in launch of needle-free drug delivery devices is predicted to boost the market growth during the forecast period. Needle-free devices offer the advantage of reducing pain and lowering the risk of infection, making them a preferred choice over conventional procedures. Consequently, there is an anticipated increase in the demand for these devices during the forecast period. For instance, in November 2023, BD (Becton, Dickinson and Company), a prominent global medical technology company, has introduced a novel needle-free blood draw technology that is designed to be used with integrated catheters. This innovation aligns with the company's objective of reducing the need for multiple needle sticks during a hospital stay. The newly developed PIVO Pro Needle-free Blood Collection Device has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Notably, it is the first and only device compatible with both integrated and extended peripheral IV catheters, including the new Nexiva Closed IV Catheter System featuring NearPort IV Access.

By technology, transdermal patch was the highest revenue-grossing segment in the global needle-free drug delivery devices market in 2023 owing to its benefits such as the maintenance of consistent drug levels, reduced side effects, & the efficient absorption of medications that may not be effectively absorbed through the gastrointestinal tract and growing regulatory approvals. For instance, in March 2022, Corium, Inc. has been granted approval by the United States Food and Drug Administration (FDA) for ADLARITY, a donepezil transdermal system. This approval allows ADLARITY to be used as a treatment for patients with Alzheimer's disease, whether they have mild, moderate, or severe dementia. Additionally, jet injectors is predicted to grow at fastest CAGR during the forecast period owing to the rapid administration, enhanced dosing precision, quicker response times, improved tissue diffusion, decreased discomfort, reduced sharp waste, & increased portability, rising advantages of these systems over traditional needle-based drug delivery devices. These advantages encompass quicker drug delivery into the bloodstream and a wider distribution of insulin in the lower layers of an individual's skin.

By application, insulin delivery was the highest revenue-grossing segment in the global needle-free drug delivery devices market in 2023 owing to the surge in prevalence of diabetes, growing adoption of unhealthy lifestyle habits, rising introduction of technologically advanced products such as insulin spray, insulin pen, inhalable insulin, insulin micropump, & other novel jet injectors. For instance, in March 2023, NuGen Medical Devices has released a report regarding its needle-free injection device, InsuJet. According to the report, InsuJet has demonstrated more than a 40% increase in insulin uptake and a notably faster onset of action in diabetic patients when compared to traditional needle injections. These findings were observed in multiple clinical studies conducted in the Netherlands. Additionally, pain management is predicted to grow at fastest CAGR during the forecast period owing to a rising number of medical conditions, including chronic pain, pain disorders, myofascial pain syndrome, arthritis, & migraines.

By end-user, hospitals & clinics was the highest revenue-grossing segment in the global needle-free drug delivery devices market in 2023 owing to the growing prevalence of chronic diseases, increasing adoption of technologically advanced devices, and rising regulatory approvals. Additionally, homecare settings is predicted to grow at fastest CAGR during the forecast period owing to the benefits of needle-free drug delivery devices include precise dosage administration, reduced pain for patients leading to improved outcomes, faster drug delivery for quicker effects, and cost-effectiveness and surge in collaborations within market players. For instance, in May 2022, Zealand Pharma A/S has entered into an asset purchase agreement with MannKind Corporation to sell the V-Go insulin delivery device for $10 million, with the potential for additional sales-based milestones. The V-Go is a wearable, patch-like insulin delivery device designed for once-daily use to aid in insulin administration.

North America region is anticipated for the highest revenue share during the forecast period owing to the presence of well-established healthcare facilities, government organizations & pharmaceutical companies are investing heavily in research & development for the management of diabetes & chronic pain, growing burden of chronic diseases such as diabetes, surge in approvals for needle-free drug delivery devices, and rising initiatives by market players. For instance, in June 2022, NovaXS Biotech has unveiled the prototype for its innovative needle-free injection therapy smart medical device. This device, named Telosis, incorporates patent-pending technology that delivers a narrow stream of medication in just 0.3 seconds, all without the need for a needle. Additionally, it assesses injection data to support informed medical decisions. The company asserts that its technology provides a straightforward and painless alternative for at-home medication delivery, making it the first remote medication and self-administration monitoring platform. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of diabetes, increasing awareness regarding potential benefits of needle-free drug delivery devices, growing research & development activities for the innovative of advanced devices, and rising launch of new products. For instance, in November 2023, NiedlFree Technologies, a company based in Hyderabad and affiliated with Transgene Biotek, has achieved significant advancements in the field of diabetes treatment. They assert that they have created Ozulin, a painless and needle-free oral insulin spray. This innovative product is designed for use by both animals and humans, offering a promising development in diabetes management.

Segmentation: Needle-Free Drug Delivery Devices Market Report 2023 - 2034

Needle-Free Drug Delivery Devices Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)

  • Transdermal Patch
  • Inhaler
  • Jet Injectors
  • Novel Needle
  • Others

Needle-Free Drug Delivery Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

  • Pain Management
  • Insulin Delivery
  • Vaccine Delivery
  • Pediatric Injections
  • Others

Needle-Free Drug Delivery Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Homecare Settings
  • Academics
  • Hospitals & Clinics
  • Research Laboratories
  • Others

Needle-Free Drug Delivery Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Needle-Free Drug Delivery Devices Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Needle-Free Drug Delivery Devices Market: Technology Estimates & Trend Analysis
7.1. Technology Segment Opportunity Analysis
7.2. Transdermal Patch
7.2.1. Transdermal Patch Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Inhaler
7.3.1. Inhaler Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Jet Injectors
7.4.1. Jet Injectors Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Novel Needle
7.5.1. Novel Needle Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Others
7.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Needle-Free Drug Delivery Devices Market: Application Estimates & Trend Analysis
8.1. Application Segment Opportunity Analysis
8.2. Pain Management
8.2.1. Pain Management Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Insulin Delivery
8.3.1. Insulin Delivery Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Vaccine Delivery
8.4.1. Vaccine Delivery Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Pediatric Injections
8.5.1. Pediatric Injections Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.6. Others
8.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Needle-Free Drug Delivery Devices Market: End-user Estimates & Trend Analysis
9.1. End-user Segment Opportunity Analysis
9.2. Homecare Settings
9.2.1. Homecare Settings Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Academics
9.3.1. Academics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Hospitals & Clinics
9.4.1. Hospitals & Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.5. Research Laboratories
9.5.1. Research Laboratories Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.6. Others
9.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Needle-Free Drug Delivery Devices Market
11.1. North America Needle-Free Drug Delivery Devices Market
11.1.1. North America Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Needle-Free Drug Delivery Devices Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
11.1.4. North America Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.1.5. North America Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Needle-Free Drug Delivery Devices Market
11.2.1. U.S. Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Needle-Free Drug Delivery Devices Market
11.3.1. Canada Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Europe Global Needle-Free Drug Delivery Devices Market
12.1. Europe Global Needle-Free Drug Delivery Devices Market
12.1.1. Europe Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Needle-Free Drug Delivery Devices Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Needle-Free Drug Delivery Devices Market
12.2.1. Germany Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. UK Global Needle-Free Drug Delivery Devices Market
12.3.1. UK Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.3.3. UK Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.3.4. UK Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. France Global Needle-Free Drug Delivery Devices Market
12.4.1. France Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.4.3. France Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.4.4. France Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Needle-Free Drug Delivery Devices Market
12.5.1. Spain Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Needle-Free Drug Delivery Devices Market
12.6.1. Italy Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Needle-Free Drug Delivery Devices Market
12.7.1. Rest of Europe Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Needle-Free Drug Delivery Devices Market
13.1. Asia Pacific Global Needle-Free Drug Delivery Devices Market
13.1.1. Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Needle-Free Drug Delivery Devices Market
13.2.1. Japan Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. China Global Needle-Free Drug Delivery Devices Market
13.3.1. China Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.3.3. China Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.3.4. China Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. India Global Needle-Free Drug Delivery Devices Market
13.4.1. India Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.4.3. India Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.4.4. India Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Needle-Free Drug Delivery Devices Market
13.5.1. South Korea Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Needle-Free Drug Delivery Devices Market
13.6.1. Australia Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Needle-Free Drug Delivery Devices Market
13.7.1. Rest of Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Latin America Global Needle-Free Drug Delivery Devices Market
14.1. Latin America Global Needle-Free Drug Delivery Devices Market
14.1.1. Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Needle-Free Drug Delivery Devices Market
14.2.1. Brazil Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Needle-Free Drug Delivery Devices Market
14.3.1. Mexico Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Needle-Free Drug Delivery Devices Market
14.4.1. Argentina Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Needle-Free Drug Delivery Devices Market
14.5.1. Rest of Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. MEA Global Needle-Free Drug Delivery Devices Market
15.1. MEA Global Needle-Free Drug Delivery Devices Market
15.1.1. MEA Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Needle-Free Drug Delivery Devices Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Needle-Free Drug Delivery Devices Market
15.2.1. GCC Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Needle-Free Drug Delivery Devices Market
15.3.1. South Africa Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Needle-Free Drug Delivery Devices Market
15.4.1. Rest of MEA Needle-Free Drug Delivery Devices Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Needle-Free Drug Delivery Devices Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Needle-Free Drug Delivery Devices Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Needle-Free Drug Delivery Devices Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. PharmaJet
17.2. Halozyme, Inc. (Antares Pharma)
17.3. Crossject
17.4. 3M
17.5. PenJet Corporation
17.6. MannKind Corporation
17.7. Zealand Pharma A/S
17.8. Zydus Group
17.9. Mika Medical Co.
17.10. Ferring B.V.
17.11. Akra Dermojet
17.12. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • PharmaJet
  • Halozyme Inc. (Antares Pharma)
  • Crossject
  • 3M
  • PenJet Corporation
  • MannKind Corporation
  • Zealand Pharma A/S
  • Zydus Group
  • Mika Medical Co.
  • Ferring B.V.
  • Akra Dermojet

Table Information